Medistim ASA (MEDI)

Currency in NOK
306.00
-2.00(-0.65%)
Closed·
Advertisement
MEDI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
301.00310.00
52 wk Range
186.50316.00
Key Statistics
Prev. Close
306
Open
306
Day's Range
301-310
52 wk Range
186.5-316
Volume
27.85K
Average Volume (3m)
18.04K
1-Year Change
12.0879%
Book Value / Share
24.88
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MEDI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
365.00
Upside
+19.28%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Medistim ASA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Strong Buy

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 365.00
(+19.28% Upside)

Medistim ASA Earnings Call Summary for Q3/2026

  • Medistim Q3 revenue surged 25.9% YoY to NOK 210M (31.5% currency-neutral); EBIT jumped 55.7% to NOK 63.1M with margin expanding to 30.1%.
  • Gross margin improved to 84.5% from 81.5% despite U.S. tariffs; EPS reached NOK 2.61 as imaging systems drove growth with 57.9% probe sales increase.
  • Company introduced quarterly dividend of NOK 2.50/share, signaling cash generation confidence; shares rose 8.9% to $306, near 52-week high of $315.
  • Management expects continued profitable growth; INTUI vascular software launch targeted for H1 2027, with 80% U.S. cardiac system adoption rate achieved.
  • Key risks include January 2027 U.S. Medicaid cuts, ongoing tariff pressures, and flat vascular segment as customers shift to cardiac systems with INTUI.
Last Updated: 23/10/2026, 09:00
Read Full Transcript

Earnings

Latest Release
23/10/2026
EPS / Forecast
2.65 / 2.13
Revenue / Forecast
210M / 189M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -
Dividend Yield
3.41%
Industry Median 2.56%
Annualised payout
10.50
Paid annually
5-Years Growth
+21.67%
Growth Streak

Compare MEDI to Peers and Sector

Metrics to compare
MEDI
Peers
Sector
Relationship
P/E Ratio
31.2x16.1x−0.3x
PEG Ratio
-0.020.00
Price/Book
12.2x2.6x2.6x
Price / LTM Sales
7.0x2.6x2.8x
Upside (Analyst Target)
20.1%12.9%64.7%
Fair Value Upside
Unlock14.5%9.6%Unlock

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and ultrasound imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which are designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation; ultrasound imaging probes; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.

Employees
159
Market
Norway

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
5.46M29.86%1.68B
Other Institutional Investors
11.06M60.44%3.41B
Public Companies & Retail Investors
1.77M9.70%546.33M
Total
18.29M100.00%5.63B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Intertrade Shipping AS12.57%2,300,001708,400
Danske Capital Denmark9.97%1,824,460561,934

People Also Watch

38.55
ALSEM
+3.21%
79.80
VETO
-1.24%
8.71
ALESE
-0.80%
19.82
MANP
+1.23%
90.80
NEDP
-0.66%

FAQ

What Is the Medistim (Oslo: MEDI) Share Price Today?

The Medistim stock price today is 306.00 NOK.

What Stock Exchange Does Medistim (MEDI) Trade On?

Medistim is listed and trades on the Oslo Stock Exchange.

What Is the Ticker (Stock Symbol) for Medistim?

The stock symbol (also called a 'ticker') for Medistim is "MEDI."

Does Medistim Pay Dividends? What’s The Current MEDI Dividend Yield?

Yes, MEDI Pays Dividends to its Shareholders. The current Medistim dividend yield is 3.4%%.

What Is the Current Medistim Market Capitalisation?

As of today, Medistim (Oslo: MEDI) market cap is 5.63B NOK.

When Is the Next Medistim Earnings Date?

Medistim's next earnings report will be released on 26/02/2027.

Is MEDI a Buy or Sell From a Technical Analyst Perspective?

Based on today's Medistim moving averages and other technical indicators, the daily buy/sell signal for MEDI stock is Strong Buy.

How Many Times Has Medistim Stock Split?

Medistim has split 0 times. (See the MEDI stock split history page for full effective split date and price information.)

How Many Employees Does Medistim Have?

Medistim has 159 employees, based on their latest Companies House report.

What is the current trading status of Medistim (Oslo: MEDI)?

As of 27/10/2026, Medistim (MEDI) is trading at a share price of 306.00 NOK, with a previous close of 306.00 NOK. The stock has fluctuated within a day range of 301.00 NOK to 310.00 NOK, while its 52-week range spans from 186.50 NOK to 316.00 NOK.

What Is Medistim (MEDI) Price Target According to Analysts?

The average 12-month price target for Medistim is 365.00 NOK, with a high estimate of 370 NOK and a low estimate of 360 NOK. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +19.28% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.